Country: United Kingdom
Language: English
Source: VMD (Veterinary Medicines Directorate)
Ferrous Sulphate Dried, Nettles Powder
Denes Natural Pet Care Ltd
Ferrous Sulphate Dried, Nettles Powder
Expired
Revised: December 2013 AN: 01103//2013 SUMMARY OF PRODUCTS CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Greenleaf Sugar Coated Tablets 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Active substances Qualitative composition Dried ferrous sulphate Nettles powder Excipients Titanium Dioxide (E171) Titanium Dioxide (E171) (as part of Mastercote Green SP3561) Curcumin Lake (E100) (as part of Mastercote Green SP3561) Chlorophyllin Copper complex Sodium (E141) (as part of Mastercote Green SP3561) Chlorophyllin Copper complex Sodium (E141) (as part of chlorophyll concentrate For full list of excipients, see section 6.1 Quantitative composition 32.0mg per tablet 41.0mg per tablet 2.50 mg per tablet 28.10 % w/w 0.10 % w/w 1.80 % w/w 9-11 % w/w 3. PHARMACEUTICAL FORM Coated Tablet Green, biconvex, circular tablets 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Dogs and cats over 2 months of age Revised: December 2013 AN: 01103//2013 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES Greenleaf tablets are a traditional herbal remedy for the symptomatic relief of respiratory conditions, digestive disorders and skin infections in dogs and cats. 4.3 CONTRAINDICATIONS Do not use on animals under 2 months of age 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES None 4.5 SPECIAL PRECAUTIONS FOR USE i. Special precautions for use in animals If the condition fails to improve after seven days, consult a veterinary surgeon. ii. Special precautions for the person administering the veterinary medicinal product to animals Wash hands after use iii. Other precautions NONE 4.6 ADVERSE REACTIONS (FREQUENCY AND SERIOUSNESS) None reported 4.7 USE DURING PREGNANCY, LACTATION OR LAY No data is available to support the use of this product in pregnant or lactating animals. Therefore, the use of this product is not recommended in pregnant or lactating animals. 4.8 INTERACTION WITH OTHER MEDICINAL PRODUCTS AND OTHER FORMS OF INTERACTION None reported. Revised: December 2013 AN: 01103//2013 4.9 AMOUNT(S) TO BE ADMINISTERED AND ADMINISTRATION Read the complete document